Human organoids with an autologous tissue-resident immune compartment.
Timothy RecaldinLinda SteinacherBruno GjetaMarius F HarterLukas AdamKristina KromerMarisa Pimentel MendesMarina BellavistaMikhail Yu NikolaevGiacomo LazzaroniRok KreseUmut KilikDoris PopovicBilgenaz StollRégine GerardMichael BscheiderMarc BickleLauriane CabonJ Gray CampNikolche GjorevskiPublished in: Nature (2024)
The intimate relationship between the epithelium and immune system is crucial for maintaining tissue homeostasis, with perturbations therein linked to autoimmune disease and cancer 1-3 . Whereas stem cell-derived organoids are powerful models of epithelial function 4 , they lack tissue-resident immune cells that are essential for capturing organ-level processes. We describe human intestinal immuno-organoids (IIOs), formed through self-organization of epithelial organoids and autologous tissue-resident memory T (T RM ) cells, a portion of which integrate within the epithelium and continuously survey the barrier. T RM cell migration and interaction with epithelial cells was orchestrated by T RM cell-enriched transcriptomic programs governing cell motility and adhesion. We combined IIOs and single-cell transcriptomics to investigate intestinal inflammation triggered by cancer-targeting biologics in patients. Inflammation was associated with the emergence of an activated population of CD8 + T cells that progressively acquired intraepithelial and cytotoxic features. The appearance of this effector population was preceded and potentiated by a T helper-1-like CD4 + population, which initially produced cytokines and subsequently became cytotoxic itself. As a system amenable to direct perturbation, IIOs allowed us to identify the Rho pathway as a new target for mitigation of immunotherapy-associated intestinal inflammation. Given that they recapitulate both the phenotypic outcomes and underlying interlineage immune interactions, IIOs can be used to study tissue-resident immune responses in the context of tumorigenesis and infectious and autoimmune diseases.
Keyphrases
- single cell
- induced pluripotent stem cells
- cell therapy
- oxidative stress
- rna seq
- cell migration
- patient safety
- immune response
- endothelial cells
- end stage renal disease
- quality improvement
- papillary thyroid
- newly diagnosed
- regulatory t cells
- dendritic cells
- multiple sclerosis
- ejection fraction
- bone marrow
- stem cells
- chronic kidney disease
- induced apoptosis
- high grade
- type diabetes
- peritoneal dialysis
- mesenchymal stem cells
- pseudomonas aeruginosa
- escherichia coli
- toll like receptor
- staphylococcus aureus
- metabolic syndrome
- biofilm formation
- prognostic factors
- platelet rich plasma
- adipose tissue
- cancer therapy
- glycemic control
- drug induced
- cell death
- signaling pathway
- candida albicans
- pi k akt